GET DAILY SIGNALSBTBT vs HIVE: Weighing Two Crypto Stocks' Shift Toward AI Infrastructure
Key Takeaways
- Both BTBT and HIVE are crypto-adjacent operators pivoting toward artificial intelligence (AI) and high-performance computing (HPC) data-center revenue, but their models and momentum differ meaningfully.
- HIVE has posted faster top-line expansion and recently secured a $350 million GPU cloud contract, while Bit Digital leans on its Ethereum (ETH) treasury and its WhiteFiber AI infrastructure stake.
- Both stocks carry elevated volatility and report net losses, making relative trend consistency and catalyst visibility the decisive factors in this comparison.
- Tickeron AI Verdict: HIVE currently presents the more favorable risk-reward profile based on revenue momentum, contracted AI backlog, and near-term catalysts.
- For deeper context, explore BTBT Major News and BTBT Today's Price Move, along with HIVE Major News and HIVE Today's Price Move.
- To see which stocks AI-driven trading systems favor right now, visit the Trending AI Robots page.
The Broader Context for These Crypto-to-AI Transitions
Bit Digital, Inc. and HIVE Digital Technologies Ltd. both started as digital-asset mining businesses and have since repositioned toward AI infrastructure. This shift has placed them in direct competition for investor attention in the HPC data-center build-out. Traders and long-term investors comparing these two names are weighing two distinct execution paths: Bit Digital's Ethereum-centric treasury strategy paired with a majority stake in WhiteFiber, versus HIVE's dual-engine model of Bitcoin mining and a rapidly scaling GPU cloud business. This comparison examines their recent performance, growth drivers, and market positioning to help assess relative strength in the current environment. I also checked sector peers using Tickeron’s AI Screener to see how these names stack up.
BTBT Overview and Recent Performance
BTBT, or Bit Digital, has evolved from Bitcoin mining into a strategic asset company centered on Ethereum treasury management, staking, and AI/HPC infrastructure. The company consolidates WhiteFiber, a data-center and cloud-services subsidiary in which it holds a majority stake. In recent quarters, cloud services have become the dominant revenue line, rising sharply on new and expanded GPU contracts, while Bitcoin mining has been deliberately wound down. Sentiment has been shaped by both the firm's growing contracted backlog, reported near roughly $1 billion in remaining performance obligations, and heavy non-cash charges tied to digital-asset mark-to-market movements. In recent weeks the share price has traded near multi-year lows, reflecting pressure from crypto price swings and a persistent discount between market value and the company's underlying assets. From what I see, the asset-heavy approach adds a layer of complexity to valuation.
HIVE Overview and Recent Performance
HIVE, or HIVE Digital Technologies, operates green-energy-powered data centers across Canada, Sweden, Paraguay, and Bermuda and pursues a dual strategy of Bitcoin mining and AI/HPC services through its BUZZ HPC subsidiary. Recent market activity has been driven by a series of infrastructure milestones, including a five-year, approximately $350 million GPU cloud agreement deploying NVIDIA Blackwell Ultra systems, additional fixed-rate project financing, and a planned large-scale AI gigafactory in the Toronto area. Revenue growth has been substantial, with mining volumes and HPC services both expanding, while profitability has remained pressured by capital spending and non-cash items. Like Bit Digital, the stock has experienced elevated volatility and traded well below its 52-week high in recent weeks, reflecting both sector-wide sentiment shifts and company-specific execution catalysts. One thing that stands out here is the concrete contract visibility.
Head-to-Head Comparison
The core contrast between these two stocks lies in how each converts its crypto legacy into AI infrastructure value. Bit Digital's model is treasury-led: it holds one of the largest public corporate Ethereum positions, earns staking yield, and uses that balance sheet to finance WhiteFiber's growth without selling ETH or issuing equity. HIVE, by contrast, is more directly operational in HPC, pairing Bitcoin mining with owned data-center capacity and a GPU cloud business targeting roughly $200 million in annual recurring revenue. On growth, HIVE has delivered faster sequential and year-over-year top-line expansion, while Bit Digital's revenue mix is shifting more rapidly toward recurring cloud and colocation services. Risk profiles differ too: Bit Digital carries meaningful digital-asset and margin-related exposure through its collateralized ETH borrowings, whereas HIVE's risks lean toward capital-intensity, financing costs, and dilution from convertible and at-the-market programs. Both remain high-beta names, but HIVE's catalyst pipeline currently appears denser. I’m watching this closely as execution on the GPU side unfolds.
Tickeron AI Verdict
Based on observable factors including revenue momentum, contracted backlog visibility, catalyst density, and relative positioning within the AI/HPC theme, Tickeron's AI would likely favor HIVE over BTBT in the current market environment. HIVE's combination of a landmark GPU cloud contract, secured project financing, and an expanding green-energy data-center footprint offers a more concrete near-term growth narrative, while Bit Digital's value story remains more contingent on Ethereum prices and the market's willingness to re-rate its WhiteFiber stake. This assessment is probabilistic rather than definitive and may shift as fundamentals, sentiment, and crypto market conditions evolve.
Enhancing Analysis with Tickeron Tools
I frequently rely on Tickeron’s AI Trading Bots to complement fundamental work on names like these. The platform’s Trending AI Robots section highlights bots with strong recent performance across various strategies and timeframes, giving a data-driven view of how automated systems are positioned in the current regime. This helps me cross-check my own observations without replacing core research.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
HIVE sees its Stochastic Oscillator climbs out of oversold territory
On October 28, 2026, the Stochastic Oscillator for HIVE moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 64 instances where the indicator left the oversold zone. In 54 of the 64 cases the stock moved higher in the following days. This puts the odds of a move higher at over 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +11.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in 213 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
HIVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In 67 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for HIVE turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 30 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
HIVE moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HIVE crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The 50-day moving average for HIVE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HIVE entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.972) is normal, around the industry mean (3.059). P/E Ratio (9.174) is within average values for comparable stocks, (6.833). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.748) among similar stocks. P/S Ratio (2.169) is also within normal values, averaging (16.899).
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. HIVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of cloud networking and enterprise Wi-Fi solution
Industry InvestmentBanksBrokers
Advertisement